Business

Job Position PurposeAct as the Amyloidosis team lead and line manager, leading a team of MAS. Shape the local strategy and ensure the delivery of scientific-medical…

The Transthyretin Amyloidosis Treatment Market is Segmented by Therapy (Targeted Therapy, Supportive Therapy, Pipeline Therapy), Type (ATTR with Polyneuropathy (…

“AL Amyloidosis Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects…

Alnylam Pharmaceuticals ALNY is a commercial-stage company that currently markets four drugs. The company first received regulatory approval in 2018 for…

(Singapore, 11.06.2026)DKSH has entered into a strategic distribution partnership with biotechnology company BridgeBio to support the regulatory evaluation and…

SINGAPORE, June 11, 2026 /PRNewswire/ -- DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient…

At AstraZeneca, we turn ideas into life-changing medicines. Working here means being entrepreneurial, thinking big, and collaborating to make the impossible a…

'Golden Years': Changing the story of ATTR-CMATTR-cardiac amyloidosis (ATTR-CM) is a progressive heart condition often mistaken for normal aging. For years,…

IntroductionAccording to Mordor Intelligence, the transthyretin amyloidosis treatment market size is expected to reach USD 7.05 billion in 2026 and is forecast to…

AbstractAimsTransthyretin amyloid cardiomyopathy (ATTR-CM) causes heart failure with substantial morbidity, mortality, and healthcare utilization. ATTRibute-CM […